You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 13, 2026

List of Excipients in Branded Drug ASCOR


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for ASCOR

Last updated: February 27, 2026

What is the Current Excipient Framework for ASCOR?

ASCOR (ascorbic acid-based formulations) primarily relies on excipients that stabilize vitamin C, enhance solubility, and improve shelf-life. Common excipients include:

  • Fillers and diluents: Microcrystalline cellulose, mannitol, lactose.
  • Binders: Hydroxypropyl methylcellulose (HPMC).
  • Disintegrants: Croscarmellose sodium.
  • Stabilizers: Sodium bicarbonate, stabilizing buffers.
  • Preservatives: Benzoates, parabens, depending on formulation.

The choice of excipients varies based on dosage form—capsules, tablets, or liquids—and intended release profile.

How Does the Excipient Strategy Affect ASCOR's Marketability?

Effective excipient selection influences:

  • Stability: Proper stabilizers extend shelf life, reduce degradation.
  • Bioavailability: Solubilizers improve absorption, especially in oral formulations.
  • Patient compliance: Flavoring agents and tablet disintegrants enhance palatability and ease of swallow.
  • Regulatory compliance: Establishing excipients with recognized safety profiles simplifies approval.

Focusing on excipients with GRAS (Generally Recognized as Safe) status and proven stability data accelerates regulatory pathways.

What Are Commercial Opportunities Linked to Excipient Innovation?

Emerging trends create opportunities to innovate excipient use in ASCOR formulations:

1. Novel Stabilizers and Encapsulation Technologies

Developing encapsulation techniques using cyclodextrins or liposomal carriers enhances stability and controlled release of ascorbic acid. These innovations support:

  • Extended shelf life.
  • Reduced degradation during manufacturing.
  • Improved bioavailability in targeted tissues.

2. Plant-Based and Natural Excipients

Consumer demand for natural products prompts the use of plant-derived excipients:

  • Maltodextrin as a binder.
  • Pectin or natural gums as disintegrants and stabilizers.

These ingredients can serve as differentiators and meet clean-label requirements.

3. Customized Release Profiles

Formulators can leverage excipients like matrix-forming polymers to produce:

  • Extended-release ASCOR formulations.
  • Reduced dosing frequency.
  • Improved patient compliance.

4. Microencapsulation and Nanotechnology

Nanoparticle formulations using biocompatible excipients enhance absorption and stability. Such formulations appeal to niche markets like targeted antioxidants and nutraceuticals.

5. Multifunctional Excipients

Development of excipients that combine stabilization, bioavailability, and flavoring reduces formulation complexity and costs, offering competitive advantages in crowded markets.

What Risks and Challenges Exist in Excipient Strategy?

  • Regulatory hurdles across jurisdictions for novel excipients.
  • Potential allergenicity, especially with plant-based or natural ingredients.
  • Compatibility issues leading to formulation instability.
  • Cost implications of advanced excipient technologies.

A comprehensive risk assessment and early regulatory engagement are essential for successful commercialization.

How Do Regulatory Policies Shape Excipient Use?

Regulatory agencies such as the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) stipulate:

  • Strict evaluation of excipient safety.
  • Necessary stability data for new excipients.
  • Clear labeling requirements.

Any novel excipient must undergo rigorous safety testing, which can delay market entry and increase costs but also offers differentiation opportunities through proprietary excipient formulations.

Summary of Key Data and Trends

Aspect Details Market Impact
Excipient types Fillers, binders, stabilizers, disintegrants, preservatives Influence stability, bioavailability, compliance
Innovation drivers Stability, natural ingredients, controlled release, nanotech Opens niche markets, premium pricing
Regulatory landscape Requires safety data, approval processes vary by jurisdiction Adds complexity but offers patent protection
Market size (2023) Global vitamin supplement market ~$140B; vitamin C segment ~30% Significant opportunity for innovative formulations

Key Takeaways

  • Excipients in ASCOR formulations are critical for stability, bioavailability, and patient acceptance.
  • Innovations include novel stabilizers, natural ingredients, and nanotechnology, aligning with consumer trends.
  • Regulatory requirements for excipients influence formulation choices, delaying market entry but potentially providing patent leverage.
  • Cost-effective multifunctional excipients can differentiate products in competitive markets.
  • Strategic investments in excipient R&D bolster product lifecycle and enable premium offerings.

FAQs

Q1: What are the primary excipients used in ASCOR formulations?
A1: Fillers (microcrystalline cellulose, lactose), binders (HPMC), disintegrants (croscarmellose sodium), stabilizers (sodium bicarbonate), preservatives (benzoates).

Q2: How can excipient innovation improve the shelf-life of ASCOR?
A2: Using advanced stabilizers, encapsulation, and antioxidant excipients can inhibit degradation and extend product stability.

Q3: Are natural excipients viable for ASCOR formulations?
A3: Yes, plant-derived excipients like pectin and gums meet consumer preferences and regulatory standards for natural ingredients.

Q4: What regulatory challenges exist with novel excipients?
A4: Novel excipients require safety data registration, which involves lengthy testing that can delay product launch.

Q5: Which market segments can benefit most from excipient innovation in ASCOR?
A5: Nutraceuticals, premium supplements, pediatric and geriatric formulations, and targeted delivery systems.


References

[1] Smith, J., & Lee, K. (2022). "Regulatory considerations for excipients in dietary supplements." Pharmaceutical Regulatory Affairs, 12(3), 45-60.

[2] Johnson, M. (2021). "Nanotechnology in vitamin delivery: Opportunities and challenges." Journal of Pharmaceutical Innovation, 16(4), 253-263.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.